Congenital Hypothyroidism

Endocrinology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program
1
Tirosint®-SOLPhase 41 trial
Active Trials
NCT05228184TerminatedEst. Mar 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
IBSA Institut BiochimiqueTirosint®-SOL

Clinical Trials (1)

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

Start: Jan 2022Est. completion: Mar 2025
Phase 4Terminated

Related Jobs in Endocrinology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space